| Literature DB >> 28231462 |
Elma Aflaki1, Wendy Westbroek1, Ellen Sidransky2.
Abstract
The discovery of a link between mutations in GBA1, encoding the lysosomal enzyme glucocerebrosidase, and the synucleinopathies directly resulted from the clinical recognition of patients with Gaucher disease with parkinsonism. Mutations in GBA1 are now the most common known genetic risk factor for several Lewy body disorders, and an inverse relationship exists between levels of glucocerebrosidase and oligomeric α-synuclein. While the underlying mechanisms are still debated, this complicated association is shedding light on the role of lysosomes in neurodegenerative disorders, demonstrating how insights from a rare disorder can direct research into the pathogenesis and therapy of seemingly unrelated common diseases. Published by Elsevier Inc.Entities:
Keywords: Gaucher disease; alpha-synuclein; autophagy; glucocerebrosidase; lysosome; parkinsonism
Mesh:
Substances:
Year: 2017 PMID: 28231462 PMCID: PMC5327952 DOI: 10.1016/j.neuron.2017.01.018
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173